publication . Article . 2016

Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview

SC, Yenisetti; Muralidhara,;
Open Access English
  • Published: 01 Jun 2016 Journal: AIMS Public Health (issn: 2327-8994, Copyright policy)
  • Publisher: AIMS Press
Abstract
Coffee is among the most widespread and healthiest beverages in the world. Coffee typically contains more caffeine than most other beverages, and is widely and frequently consumed. Thus, it contributes significantly to the overall caffeine consumption within the general population, particularly in adults. Controversies regarding its benefits and risks still exist as reliable evidence is becoming available supporting its health-promoting potential. Several lines of evidence have highlighted the beneficial effects towards several disease conditions including Type II diabetes, hepatitis C virus, hepatocellular carcinoma, nonalcoholic fatty liver disease and neurode...
Subjects
free text keywords: Coffee, caffeine, Neuroproective effects, animal/cell, models, Public aspects of medicine, RA1-1270, Review
Related Organizations
76 references, page 1 of 6

Frary, CD, Johnson, RK, Wang, MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc. 2005; 105 (1): 110-3 [PubMed]

Mitchell, DC, Knight, CA, Hockenberry, J. Beverage caffeine intakes in the U.S. Food Chem Toxicol. 2014; 63: 136-42 [PubMed]

Heckman, MA, Weil, J, Gonzalez de Mejia, E. Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010; 75: R77-R87 [OpenAIRE] [PubMed]

Letter from Jeanne Ireland, Assistant Commissioner for Legislation, FDA, to Senator Richard J. Durbin, August 10, 2012.

Bambha, K, Wilson, L, Unalp, A. Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver Int. 2014; 34: 1250-8 [OpenAIRE] [PubMed]

Freedman, ND, Park, Y, Abnet, CC. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012; 366: 1891-904 [OpenAIRE] [PubMed]

Molloy, JW, Calcagno, CJ, Williams, CD. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology. 2012; 55 (2): 429-36 [OpenAIRE] [PubMed]

Anty, R, Marjoux, S, Iannelli, A. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol. 2012; 57: 1090-6 [OpenAIRE] [PubMed]

Birerdinc, A, Stepanova, M, Pawloski, L. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012; 35: 76-82 [PubMed]

Catalano, D, Martines, G, Tonzuso, A. Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci. 2010; 55: 3200-6 [PubMed]

Gutierrez-Grobe, Y, Chavez-Tapia, N, Sanchez-Valle, V. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. Ann Hepatol. 2012; 11: 350-5 [PubMed]

Wilson, K, Kasperzyk, J, Rider, J. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst. 2011; 103: 876-84 [OpenAIRE] [PubMed]

Liu, R, Guo, X, Park, Y. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol. 2012; 175: 1200-7 [OpenAIRE] [PubMed]

Nehli, A. Effects of coffee/caffeine on brain health and disease: What should I tell my patients?. Pract Neurol. 2016; 16 (2): 89-95 [PubMed]

Beghi, E, Pupillo, E, Messina, P. Coffee and amyotrophic lateral sclerosis: a possible preventive role. Am J Epidemiol. 2011; 174: 1002-8 [OpenAIRE] [PubMed]

76 references, page 1 of 6
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue